Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
The IL-33 and IL-4Rα blocking antibodies itepekimab and dupilumab modulate both distinct and common inflammatory mediators in asthma.
Journal: Science translational medicine
Published: October 29, 2025
Development of a long-acting relaxin for the treatment of pulmonary hypertension.
Journal: British journal of pharmacology
Published: August 21, 2025
Pharmacokinetics and pharmacodynamics of itepekimab in adults with moderate-to-severe atopic dermatitis: Results from two terminated phase II trials.
Journal: Clinical and translational science
Published: February 05, 2024
Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results.
Journal: The Annals of otology, rhinology, and laryngology
Published: June 16, 2023
Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis.
Journal: The New England journal of medicine
Published: December 22, 2022
Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma.
Journal: The New England journal of medicine
Published: December 08, 2021
Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma.
Journal: The New England journal of medicine
Published: October 27, 2021
Preclinical and clinical experience with dupilumab on the correlates of live attenuated vaccines.
Journal: The journal of allergy and clinical immunology. Global
Published: October 08, 2021
The efficacy and safety of dupilumab in Chinese patients with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled study.
Journal: The British journal of dermatology
Published: August 05, 2021
Pharmacokinetics and Concentration-Response of Dupilumab in Patients With Seasonal Allergic Rhinitis.
Journal: Journal of clinical pharmacology
Published: June 11, 2021
Last Updated: 09/26/2026